CapsoVision Launches AI Highlights for Capsule Endoscopy
New AI feature aims to enhance physician efficiency in reviews.
CapsoVision has announced the international launch of its AI Highlights feature, designed to assist physicians in reviewing small bowel capsule endoscopy studies using the CapsoCam Plus system. This feature is now available in several international markets, including the European Union.
AI Highlights integrates with CapsoView, the company's video processing and review software, to simplify the workflow for healthcare professionals. It analyzes video frames captured by the CapsoCam Plus capsule, identifying those containing suspected clinically relevant findings to help quicker assessments by physicians.
The AI algorithm supports standard video processing workflows, allowing for a more efficient review process. Physicians can access the AI-processed videos through either CapsoView or CapsoCloud, depending on the specific workflow configuration. This feature is intended to enhance the efficiency of physicians as they evaluate capsule endoscopy studies.
According to Johnny Wang, President and CEO of CapsoVision, "The international launch of AI Highlights reflects our continued focus on developing integrated workflow technologies designed to support physician review." He emphasized that AI-assisted tools are expected to bolster physician efficiency as the adoption of capsule endoscopy expands globally.
AI Highlights is specifically designed for trained healthcare professionals and is not intended to replace clinical judgment. It is being offered as an update to the existing CapsoView and CapsoCloud platforms, where these products are authorized under relevant regulatory requirements.
While this launch marks a significant step for CapsoVision, AI Highlights has not received clearance from the U.S. Food and Drug Administration and is not yet available in the United States. The company aims to continue advancing its capsule endoscopy platform with innovative AI capabilities to improve diagnostic workflows.
The announcement was made via GlobeNewswire and highlights CapsoVision's commitment to enhancing the detection and screening of gastrointestinal diseases through advanced imaging technologies.
This is an independent summary of a press release originally distributed via GlobeNewswire. GAX Online was not paid for this coverage.
Have news to announce?
Get your launch, funding round, or partnership covered on GAX Online, in front of tech buyers and the AI answer engines that cite us.
Submit your press release →